Company: PTPI
Filing Date: 2025-03-14
Form Type: PRER14A
Source: 0001104659-25-024012
Chunk: 33

Company: Petros Pharmaceuticals, Inc.
Filing Date: 2025-03-14
Form: PRER14A
Chunk 33
---
 Offering. Additionally, 3i, LP
(“3i”), Five Narrow Lane LP (“Five Narrow”) and Alto Opportunity Master Fund, SPC-Segregated Master
Portfolio B, together with its affiliates (“Alto”), beneficially own more than 5% of our voting securities and
participated in the Offering. ICIG, IMF, 3i, Five Narrow and Alto may be unable exercise all of the Series Warrants issued
to them in connection with the Offering if this proposal is not approved by our stockholders. ICIG and IMF, together, and 3i, Five
Narrow and Alto may, by virtue of the issuance of the Series Warrant Shares to which each is entitled upon exercise of their
respective Series Warrants at the initial exercise price, acquire rights to a majority of the voting power of us, based on the
number of shares of Common Stock outstanding as of the Record Date.

Required Vote

The affirmative vote of the
holders of a majority of the stock having voting power present by virtual attendance or represented by proxy at the Special Meeting and
entitled to vote on the Issuance Proposal is required to approve the Issuance Proposal. “ABSTAIN” votes will have the same
effect as votes cast “AGAINST” the Issuance Proposal. Because the Issuance Proposal is not considered a routine matter, your
bank, broker, trustee or other nominee, as the case may be, will not be able to vote your shares without your instruction with respect
to the Issuance Proposal. As a result, the failure to instruct your bank, broker, trustee or other nominee as to how to vote on the Issuance
Proposal will result in a broker non-vote, which will have no effect on the results of this vote.

<div align='center'>THE BOARD OF DIRECTORS RECOMMENDS THAT YOU VOTE “FOR” THE ISSUANCE PROPOSAL
DISCLOSED IN THIS PROXY STATEMENT, AND PROXIES SOLICITED BY THE BOARD WILL BE
VOTED IN FAVOR THEREOF UNLESS A STOCKHOLDER HAS INDICATED OTHERWISE ON THE PROXY.

21

PROPOSAL NO. 2 - THE REVERSE STOCK SPLIT PROPOSAL</div>

Background and Proposed Amendment

Our Amended and Restated
Certificate of Incorporation (as amended, the “Charter”) currently authorizes the Company to issue a total of 300,000,000
shares